Home »
NYT
» Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?
Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?
By GINA KOLATA from NYT Health
https://ift.tt/2CQNI7l
Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in Medicare.
No comments:
Post a Comment